JP2022539038A5 - - Google Patents
Info
- Publication number
- JP2022539038A5 JP2022539038A5 JP2021576604A JP2021576604A JP2022539038A5 JP 2022539038 A5 JP2022539038 A5 JP 2022539038A5 JP 2021576604 A JP2021576604 A JP 2021576604A JP 2021576604 A JP2021576604 A JP 2021576604A JP 2022539038 A5 JP2022539038 A5 JP 2022539038A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962867593P | 2019-06-27 | 2019-06-27 | |
| US62/867,593 | 2019-06-27 | ||
| PCT/US2020/038115 WO2020263650A1 (en) | 2019-06-27 | 2020-06-17 | Anti-lrrc25 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022539038A JP2022539038A (ja) | 2022-09-07 |
| JPWO2020263650A5 JPWO2020263650A5 (https=) | 2023-06-26 |
| JP2022539038A5 true JP2022539038A5 (https=) | 2023-06-26 |
Family
ID=74060354
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576604A Pending JP2022539038A (ja) | 2019-06-27 | 2020-06-17 | 骨髄細胞炎症性表現型を調節するための抗ｌｒｒｃ２５組成物及び方法、ならびにその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220363752A1 (https=) |
| EP (1) | EP3990017A4 (https=) |
| JP (1) | JP2022539038A (https=) |
| KR (1) | KR20220042131A (https=) |
| CN (1) | CN114423452A (https=) |
| AU (1) | AU2020306772A1 (https=) |
| BR (1) | BR112021026411A2 (https=) |
| CA (1) | CA3142838A1 (https=) |
| IL (1) | IL289166A (https=) |
| WO (1) | WO2020263650A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3267340A1 (en) * | 2022-10-05 | 2024-04-11 | Shangpharma Innovation, Inc. | Anti-urokinase type plasminogen activator receptor antibodies and methods of use |
| CN116380755B (zh) * | 2023-03-20 | 2023-11-21 | 广州市第一人民医院（广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院） | CD127+PMN-MDSCs在诊断支气管肺发育不良中的应用及诊断试剂盒 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101122628B1 (ko) * | 2009-02-16 | 2012-04-12 | 한국화학연구원 | 노닐페놀에 의해 유도된 생식독성 진단용 바이오마커 및 이를 이용한 생식독성 진단 방법 |
| US10279018B2 (en) * | 2012-12-03 | 2019-05-07 | Unity Biotechnology, Inc. | Immunogenic compositions for inducing an immune response for elimination of senescent cells |
| WO2016203053A2 (en) * | 2015-06-18 | 2016-12-22 | Thomas Mole Herd | Methods of characterising cancer |
| WO2017004153A1 (en) * | 2015-06-29 | 2017-01-05 | The Broad Institute Inc. | Tumor and microenvironment gene expression, compositions of matter and methods of use thereof |
| JP7078533B2 (ja) * | 2015-10-21 | 2022-05-31 | オーエスイー イムノセラピューティクス | 炎症促進性細胞へのマクロファージ分極を改変して癌を治療するための抗ＳＩＲＰａ化合物 |
| CN109313201B (zh) * | 2016-06-14 | 2022-04-01 | 高级生物设计公司 | 用于监测细胞凋亡的特异于γ-谷氨酰基-L-ε-赖氨酸(GGEL)的单克隆抗体 |
| US20190233534A1 (en) * | 2016-07-14 | 2019-08-01 | Fred Hutchinson Cancer Research Center | Multiple bi-specific binding domain constructs with different epitope binding to treat cancer |
| JP2021529753A (ja) * | 2018-06-29 | 2021-11-04 | ヴェルソー セラピューティクス， インコーポレイテッド | 単球及びマクロファージの炎症性表現型を調節するための組成物及び方法、ならびにそれを使用する免疫療法 |
-
2020
- 2020-06-17 CA CA3142838A patent/CA3142838A1/en active Pending
- 2020-06-17 EP EP20833200.7A patent/EP3990017A4/en not_active Withdrawn
- 2020-06-17 CN CN202080061285.3A patent/CN114423452A/zh active Pending
- 2020-06-17 KR KR1020227003081A patent/KR20220042131A/ko not_active Ceased
- 2020-06-17 WO PCT/US2020/038115 patent/WO2020263650A1/en not_active Ceased
- 2020-06-17 BR BR112021026411A patent/BR112021026411A2/pt not_active IP Right Cessation
- 2020-06-17 US US17/620,264 patent/US20220363752A1/en not_active Abandoned
- 2020-06-17 AU AU2020306772A patent/AU2020306772A1/en not_active Abandoned
- 2020-06-17 JP JP2021576604A patent/JP2022539038A/ja active Pending
-
2021
- 2021-12-20 IL IL289166A patent/IL289166A/en unknown